Goldman Sachs ActiveBeta World Low Vol Plus Equity ETF (GLOV)

Dr. Kalinski is the sponsor, NWBO is one of the collaborators.

Are you really letting a keyboard warrior getting under your skin, come on buddy! There is nothing anybody says on this sht show forum that means 2 fks to anyone. Don’t let this hub get to you bro. This whole hub is a sht show

Al-Than's bloated resume'--- Prior to his current role (with Ameerex), he served as the Assistant CEO of Qatar General Group (a major Qatari insurance and investment conglomerate) from 2015 until 2020, where he honed his expertise in managing massive multi-billion-Riyal investment portfolios . Yeah

"It is being 'shorted' so *Insiders* can 'scoop up' the Cheap shares OR are you saying we could expect these shares will be given to "WamU Escrow-holders for our Assets? "

NEITHER. The theory goes that there's apparently 100's of Millions of Class-L shares that are going to be convert

https://x.com/PikachOTC/status/2062848269726728334

ENZC

The stock price after submittal says it all. Little to no one cares about this anymore in my opinion.

I do have trading shares in Ira.though.never sold in other acct.

We've been trading in a channel the past three months. And we traded within that channel today. I was hoping the latest news would push us past $.01.

News of returning shares to the Treasury would do it, I bet.

The flaw in your argument is a class/category error.

You are applying a tissue-agnostic biomarker framework developed for a specific new class of oncology drugs — molecularly targeted therapies — to a different new class of treatment: dendritic-cell immunotherapy.

Those

More specific.

Sure.

Quick question.

When the FDA turned down RDGL's submission in August 2025, was it an EFS IDE submission or an IDE submission?

Tomorrow
Should
Be
Interesting

Even though the stock price is not going as expected 

Single large dose CART is not going to work. Kimmtrak is like a weekly low dose CART

I’ve always been long and never sold a share but when I said was short ya all said at least your telling the truth.My first buy was a year ago at.98.truth

Some of those 10 million shares that convert to 200+some cheers were also for some of the Coretec old management/board members. I have to look back; it's been almost two years.
When they file, we will know exactly who gets what.
If they want to uplist to NASDAQ, they aren't going to co

Be more specific, as they waisted few years at the beginning trying for DeNovo when they should have known FDA would never giveClass 2 designation to Radiogel.  After that, it has always been EFS IDE.   Just the earlier EFS submissions were MK doing it on his own. This current EFS IDE is with a John

BCBC BULLCHIT

Doesn't BCBC ever go up?

SPX Support---Retrace Fibs 7401---7329 ! (SPY Resistance Fibs 742.38---745.79---Support Fibs 738.17----731.35)

They certainly AREN'T waiting untold 2 weeks before data lock at the end of a trial. And they are also not with unapproved ECA trial selection -- especially trials with less healthy patients in the screeners (biopsies allowed, not full resections). None of the actual selections and the timing are

The PR affirms a legal opening for the Bank ( Plaintiff ) to go to Court to seek a Post Judgment Receiver because the PR openly admitted in its June 5th press release that it has deliberately pulled all depository accounts out of the United States to avoid enforcement. Plus adding grounds that Ameer

https://www.thelist.com/2186017/one-move-confirms-jeff-bezos-ex-wife-mackenzie-scott-not-interested-in-publicity/

Mackenzie, why don’t you teach a giving/philanthropy class for billionaires??? You could send Elon to the principal’s office!!! Lololol!!!! Seriously, why don’t you tea

CSL Vifor would highly prefer to wait until oxylanthanum carbonate (OLC) is officially approved before initiating an acquisition, but they might consider a heavily structured licensing deal prior to approval to secure the asset.

As a massive specialty pharmaceutical company, CSL Vifor